PRDM9 and melanoma: Indeed, Zingg et al. reported that overexpression of histone methyltransferase EZH2 in melanoma cells contributes to ICI resistance by decreasing the intra-tumoral interferon-γ-producing PD-1low CD8+T cell infiltration.